Related references
Note: Only part of the references are listed.The Structure and Functions of P-Glycoprotein
Y. Li et al.
CURRENT MEDICINAL CHEMISTRY (2010)
An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene
Margarita L. Guenova et al.
HEMATOLOGY (2010)
Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
H-W Xu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Multidrug Resistance Through the Spectacle of P-Glycoprotein
Katalin Goda et al.
CURRENT CANCER DRUG TARGETS (2009)
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type
Biyun Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
Uros Potocnik et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Genuine functions of P-glycoprotein (ABCB1)
Takaharu Mizutani et al.
CURRENT DRUG METABOLISM (2008)
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins
Jerry E. Chipuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multidrug resistance in gastric cancer: Recent research advances and ongoing therapeutic challenges
Dexin Zhang et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines
Michela Solazzo et al.
EXPERIMENTAL CELL RESEARCH (2006)
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells
I Mantovani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells
E Munteanu et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Overlapping gene expression in fetal mouse intestine development and human colorectal cancer
M Hu et al.
CANCER RESEARCH (2005)
Expression of COX-2, mPGE-synthase1, MDR-I (P-gp), and Bcl-XL:: a molecular pathway of H pylori-related gastric carcinogenesis
G Nardone et al.
JOURNAL OF PATHOLOGY (2004)
Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats
J Kankesan et al.
CARCINOGENESIS (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux
KM Tainton et al.
CELL DEATH AND DIFFERENTIATION (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Helicobacter pylori and molecular events in precancerous gastric lesions
G Nardone et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
MRE11 expression is impaired in gastric cancer with microsatellite instability
L Ottini et al.
CARCINOGENESIS (2004)
The Hedgehog response network: Sensors, switches, and routers
L Lum et al.
SCIENCE (2004)
Effect of PSC 833, an inhibitor of P-glycoprotein, on 1,2-dimethylhydrazine-induced liver carcinogenesis in rats
J Kankesan et al.
CARCINOGENESIS (2003)
P-glycoprotein increases from proximal to distal regions of human small intestine
S Mouly et al.
PHARMACEUTICAL RESEARCH (2003)
The role of P-glycoprotein in intestinal tumorigenesis:: disruption of mdr1a suppresses polyp formation in ApcMin/+ mice
Y Mochida et al.
CARCINOGENESIS (2003)
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
M van Rijnsoever et al.
GUT (2002)
Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer
JP Van Brussel et al.
JOURNAL OF UROLOGY (2001)